SLRX logo

Salarius Pharmaceuticals (SLRX) EBITDA

Annual EBITDA

-$12.88 M
+$10.08 M+43.90%

December 31, 2023

Summary

Performance

1-Year Change

+43.9%

3-Year Change

-69.7%

5-Year Change

+41.02%

15-Year Change

+62.55%

SLRX EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

60.5%
SLRX annual EBITDA is higher than 60.5% of companies in Healthcare sector

High & Low

All-time High

-$7.59 M

3-Year Low

-$22.97 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
SLRX previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 28, 2025
SLRX next annual earnings announcement is scheduled for Feb 28, 2025

OtherSLRXprofitabilitymetrics:

Annual Revenue

-
SLRX annual revenue value is unknown

Annual Net Income

-$12.54 M
SLRX annual net profit is -$12.54 million

Annual EBIT

-$12.89 M
SLRX annual earnings before interest & taxes is -$12.89 million

Annual EPS

-$30.72
SLRX annual earnings per share is -$30.72

Quarterly EBITDA

-$1.01 M
+$461.00 K+31.44%

September 30, 2024

Summary

Performance

3-Month Change

+31.44%

1-Year Change

+43.21%

3-Year Change

+74.67%

5-Year Change

+74.67%

SLRX Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

68.98%
SLRX quarterly EBITDA is higher than 68.98% of companies in Healthcare sector

High & Low

All-time High

-$829.60 K

3-Year Low

-$6.48 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
SLRX previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
SLRX next earnings announcement is scheduled for Feb 28, 2025

OtherSLRXprofitabilitymetrics:

Quarterly Revenue

-
SLRX quarterly revenue value is unknown

Quarterly Net Income

-$972.10 K
SLRX quarterly net profit is -$972.10 thousand

Quarterly EBIT

-$1.01 M
SLRX quarterly earnings before interest & taxes is -$1.01 million

Quarterly EPS

-$0.76
SLRX quarterly earnings per share is -$0.76

TTM EBITDA

-$5.21 M
+$1.52 M+22.59%

September 30, 2024

Summary

Performance

3-Month Change

+22.59%

1-Year Change

+43.57%

3-Year Change

+75.74%

5-Year Change

+75.74%

SLRX TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

70.51%
SLRX TTM EBITDA is higher than 70.51% of companies in Healthcare sector

High & Low

All-time High

-$2.19 M

3-Year Low

-$22.97 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
SLRX previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
SLRX next earnings announcement is scheduled for Feb 28, 2025

OtherSLRXprofitabilitymetrics:

TTM Revenue

-
SLRX TTM revenue value is unknown

TTM Net Income

-$4.99 M
SLRX TTM net profit is -$4.99 million

TTM EBIT

-$5.22 M
SLRX TTM earnings before interest & taxes is -$5.22 million

TTM EPS

-$6.42
SLRX TTM earnings per share is -$6.42

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$12.88 M
SLRX annual EBITDA is -$12.88 million

Annual Net Income

-$12.54 M
SLRX annual net profit is -$12.54 million

Annual Interest Expense

-
SLRX annual interest expense value is unknown

Annual Income Tax

-
SLRX annual income tax value is unknown

Annual D&A

$10.10 K
SLRX annual depreciation & amortization is $10.10 thousand

SLRX EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+43.9%+43.2%+43.6%
3 y3 years-69.7%+74.7%+75.7%
5 y5 years+41.0%+74.7%+75.7%

SLRX EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-0.7%+43.9%-3.7%+84.5%at high+77.3%
5 y5-year-69.7%+43.9%-3.7%+84.5%at high+77.3%
alltimeall time-69.7%+67.5%-21.2%+91.2%-137.7%+86.9%

Salarius Pharmaceuticals EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
-$1.01 M(-31.4%)
-$5.21 M(-22.6%)
Jun 2024
-
-$1.47 M(-17.2%)
-$6.73 M(-27.1%)
Mar 2024
-
-$1.77 M(+82.6%)
-$9.24 M(-28.3%)
Dec 2023
-$12.88 M(-43.9%)
-$969.60 K(-61.6%)
-$12.88 M(-29.9%)
Sep 2023
-
-$2.53 M(-36.4%)
-$18.39 M(-14.4%)
Jun 2023
-
-$3.97 M(-26.7%)
-$21.49 M(-3.5%)
Mar 2023
-
-$5.42 M(-16.3%)
-$22.27 M(-3.0%)
Dec 2022
-$22.97 M(+79.5%)
-$6.48 M(+15.2%)
-$22.97 M(+11.3%)
Sep 2022
-
-$5.62 M(+18.1%)
-$20.63 M(+10.0%)
Jun 2022
-
-$4.76 M(-22.2%)
-$18.75 M(+9.6%)
Mar 2022
-
-$6.11 M(+47.6%)
-$17.11 M(+33.7%)
Dec 2021
-$12.79 M(+68.5%)
-$4.14 M(+10.6%)
-$12.79 M(+22.9%)
Sep 2021
-
-$3.74 M(+20.2%)
-$10.41 M(+23.6%)
Jun 2021
-
-$3.11 M(+72.9%)
-$8.42 M(+19.8%)
Mar 2021
-
-$1.80 M(+2.5%)
-$7.03 M(-7.4%)
Dec 2020
-$7.59 M(-6.7%)
-$1.76 M(+0.1%)
-$7.59 M(-3.8%)
Sep 2020
-
-$1.75 M(+2.1%)
-$7.89 M(-20.2%)
Jun 2020
-
-$1.72 M(-27.4%)
-$9.89 M(+9.9%)
Mar 2020
-
-$2.37 M(+15.2%)
-$9.00 M(+1.8%)
Dec 2019
-$8.14 M
-$2.05 M(-45.3%)
-$8.85 M(+1.0%)
DateAnnualQuarterlyTTM
Sep 2019
-
-$3.76 M(+352.7%)
-$8.76 M(+15.0%)
Jun 2019
-
-$829.60 K(-62.4%)
-$7.62 M(-51.9%)
Mar 2019
-
-$2.21 M(+12.0%)
-$15.83 M(-27.5%)
Dec 2018
-$21.85 M(-36.5%)
-$1.97 M(-24.6%)
-$21.85 M(-21.7%)
Sep 2018
-
-$2.61 M(-71.1%)
-$27.90 M(-19.4%)
Jun 2018
-
-$9.04 M(+10.0%)
-$34.61 M(+0.7%)
Mar 2018
-
-$8.22 M(+2.5%)
-$34.37 M(-0.1%)
Dec 2017
-$34.40 M(-13.1%)
-$8.02 M(-14.1%)
-$34.40 M(+0.4%)
Sep 2017
-
-$9.33 M(+6.1%)
-$34.25 M(-3.7%)
Jun 2017
-
-$8.80 M(+6.6%)
-$35.58 M(-6.8%)
Mar 2017
-
-$8.25 M(+4.9%)
-$38.20 M(-3.6%)
Dec 2016
-$39.61 M(+35.8%)
-$7.87 M(-26.1%)
-$39.61 M(-0.1%)
Sep 2016
-
-$10.66 M(-6.6%)
-$39.65 M(+6.8%)
Jun 2016
-
-$11.41 M(+18.1%)
-$37.15 M(+13.2%)
Mar 2016
-
-$9.66 M(+22.1%)
-$32.82 M(+12.5%)
Dec 2015
-$29.16 M
-$7.92 M(-2.9%)
-$29.16 M(+37.3%)
Sep 2015
-
-$8.15 M(+15.1%)
-$21.25 M(+40.8%)
Jun 2015
-
-$7.08 M(+17.8%)
-$15.09 M(+48.0%)
Mar 2015
-
-$6.01 M(+201.6%)
-$10.20 M(+143.6%)
Sep 2014
-
-$1.99 M(-9.1%)
-$4.19 M(+90.9%)
Jun 2014
-
-$2.19 M
-$2.19 M

FAQ

  • What is Salarius Pharmaceuticals annual EBITDA?
  • What is the all time high annual EBITDA for Salarius Pharmaceuticals?
  • What is Salarius Pharmaceuticals annual EBITDA year-on-year change?
  • What is Salarius Pharmaceuticals quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Salarius Pharmaceuticals?
  • What is Salarius Pharmaceuticals quarterly EBITDA year-on-year change?
  • What is Salarius Pharmaceuticals TTM EBITDA?
  • What is the all time high TTM EBITDA for Salarius Pharmaceuticals?
  • What is Salarius Pharmaceuticals TTM EBITDA year-on-year change?

What is Salarius Pharmaceuticals annual EBITDA?

The current annual EBITDA of SLRX is -$12.88 M

What is the all time high annual EBITDA for Salarius Pharmaceuticals?

Salarius Pharmaceuticals all-time high annual EBITDA is -$7.59 M

What is Salarius Pharmaceuticals annual EBITDA year-on-year change?

Over the past year, SLRX annual EBITDA has changed by +$10.08 M (+43.90%)

What is Salarius Pharmaceuticals quarterly EBITDA?

The current quarterly EBITDA of SLRX is -$1.01 M

What is the all time high quarterly EBITDA for Salarius Pharmaceuticals?

Salarius Pharmaceuticals all-time high quarterly EBITDA is -$829.60 K

What is Salarius Pharmaceuticals quarterly EBITDA year-on-year change?

Over the past year, SLRX quarterly EBITDA has changed by +$765.10 K (+43.21%)

What is Salarius Pharmaceuticals TTM EBITDA?

The current TTM EBITDA of SLRX is -$5.21 M

What is the all time high TTM EBITDA for Salarius Pharmaceuticals?

Salarius Pharmaceuticals all-time high TTM EBITDA is -$2.19 M

What is Salarius Pharmaceuticals TTM EBITDA year-on-year change?

Over the past year, SLRX TTM EBITDA has changed by +$4.02 M (+43.57%)